Aguilar-de-Leyva Á - Search Results

1

3D Printing Direct Powder Extrusion in the Production of Drug Delivery Systems: State of the Art and Future Perspectives.

Aguilar-de-Leyva Á, Casas M, Ferrero C, Linares V, Caraballo I. Aguilar-de-Leyva Á, et al. Pharmaceutics. 2024 Mar 22;16(4):437. doi: 10.3390/pharmaceutics16040437. Pharmaceutics. 2024. PMID: 38675099 Free PMC article. Review.

2

Extrusion-based technologies for 3D printing: a comparative study of the processability of thermoplastic polyurethane-based formulations.

Aguilar-de-Leyva Á, Linares V, Domínguez-Robles J, Casas M, Caraballo I. Aguilar-de-Leyva Á, et al. Pharm Dev Technol. 2023 Dec;28(10):939-947. doi: 10.1080/10837450.2023.2274945. Epub 2023 Dec 18. Pharm Dev Technol. 2023. PMID: 37878535

3

3D Printed Fractal-like Structures with High Percentage of Drug for Zero-Order Colonic Release.

Linares V, Aguilar-de-Leyva Á, Casas M, Caraballo I. Linares V, et al. Among authors: aguilar de leyva a. Pharmaceutics. 2022 Oct 26;14(11):2298. doi: 10.3390/pharmaceutics14112298. Pharmaceutics. 2022. PMID: 36365117 Free PMC article.

4

3D Printed Drug Delivery Systems Based on Natural Products.

Aguilar-de-Leyva Á, Linares V, Casas M, Caraballo I. Aguilar-de-Leyva Á, et al. Pharmaceutics. 2020 Jul 3;12(7):620. doi: 10.3390/pharmaceutics12070620. Pharmaceutics. 2020. PMID: 32635214 Free PMC article. Review.

5

Development and characterization of new functionalized polyurethanes for sustained and site-specific drug release in the gastrointestinal tract.

Campiñez MD, Benito E, Romero-Azogil L, Aguilar-de-Leyva Á, García-Martín MG, Galbis JA, Caraballo I. Campiñez MD, et al. Among authors: aguilar de leyva a. Eur J Pharm Sci. 2017 Mar 30;100:285-295. doi: 10.1016/j.ejps.2017.01.017. Epub 2017 Jan 17. Eur J Pharm Sci. 2017. PMID: 28108361

6

Towards a rational basis for selection of excipients: Excipient Efficiency for controlled release.

Casas M, Aguilar-de-Leyva Á, Caraballo I. Casas M, et al. Among authors: aguilar de leyva a. Int J Pharm. 2015 Oct 15;494(1):288-95. doi: 10.1016/j.ijpharm.2015.08.002. Epub 2015 Aug 4. Int J Pharm. 2015. PMID: 26253376

7

A new biodegradable polythiourethane as controlled release matrix polymer.

Campiñez MD, Ferris C, de Paz MV, Aguilar-de-Leyva A, Galbis J, Caraballo I. Campiñez MD, et al. Among authors: aguilar de leyva a. Int J Pharm. 2015 Mar 1;480(1-2):63-72. doi: 10.1016/j.ijpharm.2015.01.011. Epub 2015 Jan 8. Int J Pharm. 2015. PMID: 25579868

8

Study of the properties of the new biodegradable polyurethane PU (TEG-HMDI) as matrix forming excipient for controlled drug delivery.

Campiñez MD, Aguilar-de-Leyva Á, Ferris C, de Paz MV, Galbis JA, Caraballo I. Campiñez MD, et al. Among authors: aguilar de leyva a. Drug Dev Ind Pharm. 2013 Nov;39(11):1758-64. doi: 10.3109/03639045.2012.736516. Drug Dev Ind Pharm. 2013. PMID: 24087856

9

A new deferiprone controlled release system obtained by ultrasound-assisted compression.

Aguilar-De-Leyva A, Gonçalves-Araujo T, Daza V, Caraballo I. Aguilar-De-Leyva A, et al. Pharm Dev Technol. 2014 Sep;19(6):728-34. doi: 10.3109/10837450.2013.829091. Epub 2013 Aug 28. Pharm Dev Technol. 2014. PMID: 23984972

10

Critical points in ethylcellulose matrices: influence of the polymer, drug and filler properties.

Cifuentes C, Aguilar-de-Leyva A, Rajabi-Siahboomi AR, Caraballo I. Cifuentes C, et al. Among authors: aguilar de leyva a. Acta Pharm. 2013 Mar;63(1):115-29. doi: 10.2478/acph-2013-0005. Acta Pharm. 2013. PMID: 23482317 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13 results

Search Page

Filters